© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Reviva Pharmaceuticals Holdings, Inc. (RVPH) shows an Average True Range (ATR) of 0.07 and an Enterprise Value of 79.56M. Its average trading volume over the past 3 months is 9.67M, indicating liquidity. These fundamental metrics provide insight into RVPH's underlying financial health and market activity.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) technical indicators as of December 22, 2025: the SMA 20 is -0.73%, SMA 50 at 3.7%, and SMA 200 at -5.85%. The RSI 14 value is 50.1, suggesting its current momentum. These technical analysis signals help assess RVPH's price trends and potential future movements.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock performance overview as of December 22, 2025: The 52-week high is $2.17 (currently -72.4% below), and the 52-week low is $0.252 (currently 137.47% above). Over the past year, RVPH's performance is -77.05%, compared to the S&P 500's 12.87% change.
According to market data, Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock's recent performance metrics show that over the last month, RVPH is 12.64%, with a Year-to-Date (YTD) performance of -66.91%. Over the past year, the stock has seen a -77.05% change. These figures summarize RVPH's price movements across various periods, reflecting its historical returns.
According to current financial data, RVPH stock's P/E (TTM) ratio is -1.91, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for RVPH, including P/S (N/A), P/B (9.57), and P/FCF (-1.46), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.